Last reviewed · How we verify
Cardiac Decompensation
Approved treatments
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container · Pfizer Inc.
Direct-acting inotropic agent stimulating cardiac beta-receptors with mild chronotropic and vasodilative effects. - Dobutamine Hydrochloride In Dextrose 5% In Plastic Container
- Dobutamin · Competence Network for Congenital Heart Defects
Clinical guidelines
- FDA label — 1L
Dobutamine Hydrochloride in 5% Dextrose Injection is indicated for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting from organic heart disease. - FDA label — 1L
Dobutamine Hydrochloride in 5% Dextrose Injection is indicated for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting from cardiac surgical procedures. - FDA label — 1L
Dobutamine Hydrochloride in 5% Dextrose Injection can be used for inotropic support in the short-term treatment of patients with cardiogenic shock. - FDA label — 1L
Dobutamine Hydrochloride in 5% Dextrose Injection is indicated for inotropic support in the short-term treatment of patients with decompensated cardiac failure. - FDA label — 1L
Dobutamine Hydrochloride in 5% Dextrose Injection is indicated for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting from organic cardiac disease. - FDA label — any
Dobutamine Hydrochloride in 5% Dextrose Injection can be used for stress echocardiography.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cardiac Decompensation patent landscape — cliff calendar, originator estates, attackable patents
- Cardiac Decompensation treatment landscape brief
- Cardiac Decompensation treatment updates RSS
Frequently asked questions about Cardiac Decompensation
What drugs treat Cardiac Decompensation?
Tracked treatments include Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Dobutamin.
What is the treatment for Cardiac Decompensation?
Standard treatment for Cardiac Decompensation includes Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Dobutamin. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Cardiac Decompensation?
FDA label publishes guidelines for Cardiac Decompensation. 6 guideline references tracked.
Related
- Treatment landscape: Cardiac Decompensation patent cliff · Cardiac Decompensation CI report
- Treatment: Dobutamine Hydrochloride In Dextrose 5% In Plastic Container · Pfizer Inc.
- Treatment: Dobutamine Hydrochloride In Dextrose 5% In Plastic Container
- Treatment: Dobutamin · Competence Network for Congenital Heart Defects
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing